MAPT and frontotemporal dementia: To investigate the pathways responsible for early cognitive impairment in tauopathy and their amenability to treatment with a multi-target kinase inhibitor, we used the rTg4510 tau transgenic mouse model of frontotemporal lobar degeneration (FTLD).